Visualitzant per autor/a "Iglesias-Fernández, Javier"
Ara mostrant els elements 1-1 de 1
-
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
Barreiro, Antonio; Prenafeta, Antoni; Bech-Sabat, Gregori; Roca, Mercè; Perozo Mur, Eva; March, Ricard; González-González, Luis; Madrenas, Laia; Corominas, Júlia; Fernández, Alex; Moros, Alexandra; Cañete, Manuel; Molas, Merce; Pentinat-Pelegrin, Thais; Panosa, Clara; Moreno, Alberto; Puigvert Molas, Ester; Pol Vilarrassa, Eva; Palmada, Jordi; Garriga, Carme; Prat Cabañas, Teresa; Iglesias-Fernández, Javier; Vergara-Alert, Júlia; Lorca-Oró, Cristina; Roca, Núria; Fernández-Bastit, Leira; Rodon, Jordi; Pérez, Mònica; Segalés, Joaquim; Pradenas, Edwards; Marfil, Silvia; Trinité, Benjamin; Ortiz, Raquel; Clotet, Bonaventura; Blanco, Julià; Díaz Pedroza, Jorge; Ampudia Carrasco, Rosa; Rosales Salgado, Yaiza; Loubat-Casanovas, Jordina; Capdevila Larripa, Sara; Garcia Prado, Julia; Barretina, Jordi; Sisteré-Oró, Marta; Cebollada Rica, Paula; Meyerhans, Andreas; Ferrer, Laura (iScience, 2023-02-02) Sanitat AnimalCurrent COVID-19 vaccines have been associated with a decline in infection rates, prevention of severe disease, and a decrease in mortality rates. However, SARSCoV-2 variants are continuously evolving, ...